Sequoia Capital China

Sequoia China Investment Management LLP is a venture capital firm specializing in seed stage, start-up, early stage, mid stage, late stage, and growth stage investments. It primarily invests in the field of technology/media, telecommunications, enterprise services, medical healthcare, new drugs, new diagnostic techniques, ophthalmology, consumer products/consumer services, consumer upgrade, logistics, supply chain, advanced manufacturing, robots, industrial technology, carbon neutrality, changes brought about by artificial intelligence technology on new drug development, and biomedical innovation with focus on gene therapy, gene sequencing, and gene editing. The firm prefers to invest in the primary and secondary markets. Sequoia Capital China Fund was founded in September 2005 and is based in Beijing, China with additional offices in Admiralty, Hong Kong; Shanghai, China; Bengaluru & New Delhi, India; Singapore; Tel-Aviv, Israel; and Menlo Partk, California. Sequoia China Investment Management LLP operates as a subsidiary of Sequoia Capital Operations LLC.